112 related articles for article (PubMed ID: 8551665)
1. An early phase II study of etoposide (VP-16) in advanced gastric cancer.
Yamao T; Shimada Y; Ohtsu A; Hosokawa K; Shirao K; Kondo H; Fukuda H; Saito D; Yoshida S
Jpn J Clin Oncol; 1996 Feb; 26(1):36-41. PubMed ID: 8551665
[TBL] [Abstract][Full Text] [Related]
2. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancer.
Chiou TJ; Tung SL; Hsieh RK; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
Jpn J Clin Oncol; 1998 May; 28(5):318-22. PubMed ID: 9703859
[TBL] [Abstract][Full Text] [Related]
4. [Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].
Lou F; Zhu YH; Pan HM
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):75-8. PubMed ID: 19538878
[TBL] [Abstract][Full Text] [Related]
5. [A phase II study of SM-5887 for advanced gastric cancer].
Tsushima K; Sakata Y; Munakata A; Sato T; Chiba Y; Nara H; Kawazu S; Matsukawa M; Ohmi T; Aizawa T
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1151-4. PubMed ID: 1647150
[TBL] [Abstract][Full Text] [Related]
6. [A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)].
Mai M; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N; Taguchi T; Furue H
Gan To Kagaku Ryoho; 1999 Mar; 26(4):487-96. PubMed ID: 10097745
[TBL] [Abstract][Full Text] [Related]
7. [Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group].
Ikeda M; Noda K; Hiura M; Tamaya T; Ozaki M; Hatae M; Ozawa M; Yamabe T; Tanaka K; Izumi R; Okada H; Ogita Y; Hoshiai H
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2249-57. PubMed ID: 9881082
[TBL] [Abstract][Full Text] [Related]
8. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
Masuda N; Fukuoka M; Kudoh S; Matsui K; Kusunoki Y; Takada M; Nakagawa K; Hirashima T; Tsukada H; Yana T
J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group.
Asamoto H; Kawahara M; Iwami F; Kuba M; Furuse K; Tamura T; Saijo N; Shimoyama M
Jpn J Clin Oncol; 1998 Dec; 28(12):745-8. PubMed ID: 9879292
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
[TBL] [Abstract][Full Text] [Related]
11. [An early phase II clinical study of RP56976 (docetaxel) in patients with cancer of the gastrointestinal tract].
Taguchi T
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2431-7. PubMed ID: 7944488
[TBL] [Abstract][Full Text] [Related]
12. [Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group].
Noda K; Tanaka K; Ozaki M; Hirabayasi K; Hasegawa K; Nishiya I; Yakushiji M; Izumi R; Tomoda Y; Ogita Y; Sugimori H; Yamabe T; Kudo R; Yajima A; Terashima Y; Fujii S; Suzuoki Y; Okada H; Kono I; Ochiai K; Yamamoto T; Ikeda M; Umesaki N; Saito T; Niitani H
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2061-8. PubMed ID: 9838908
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract.
Braybrooke JP; O'Byrne KJ; Saunders MP; Propper DJ; Salisbury AJ; Boardman P; Taylor M; Ganesan TS; Talbot DC; Harris AL
Ann Oncol; 1997 Mar; 8(3):294-6. PubMed ID: 9137801
[TBL] [Abstract][Full Text] [Related]
14. [Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group].
Futatsuki K; Wakui A; Nakao I; Sakata Y; Kambe M; Shimada Y; Yoshino M; Taguchi T; Ogawa N
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1033-8. PubMed ID: 8210254
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
[TBL] [Abstract][Full Text] [Related]
16. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
17. Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Rose PG; Blessing JA; Buller RE; Mannel RS; Webster KD
Gynecol Oncol; 2003 May; 89(2):267-70. PubMed ID: 12713990
[TBL] [Abstract][Full Text] [Related]
18. Treatment of gastric adenocarcinoma with the combination of etoposide, adriamycin and cisplatin (EAP): comparison between two schedules.
Haim N; Tsalik M; Robinson E
Oncology; 1994; 51(1):102-7. PubMed ID: 8265093
[TBL] [Abstract][Full Text] [Related]
19. Phase I and pharmacologic study of 7- and 21-day continuous etoposide infusion in patients with advanced cancer.
Robert F; Chen S; Miller AA; Lee BC; Molthrop DC; Wheeler RH
Cancer Chemother Pharmacol; 1996; 38(5):459-65. PubMed ID: 8765440
[TBL] [Abstract][Full Text] [Related]
20. [Phase II study of epirubicin on gastric cancer--a cooperative study of the Tokai Cancer Chemotherapy Group].
Kimura K; Suga S; Kano H; Sakakibara K; Hayashi T; Nakai T; Nagano I; Yokoyama Y; Morise K; Hayakawa M
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2440-5. PubMed ID: 3460530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]